Novavax said Australia canceled certain doses of the company’s COVID-19 vaccine in an amendment to their 2020 advanced purchase agreement.
- Will credit about $31m of advanced payment against outstanding invoices and invoices for the future delivery of about 3m doses
- Doses were scheduled for delivery between the fourth quarter of 2023 and the fourth quarter of 2025
- Also updated vaccine delivery schedule through 2029
To view the source of this information, click
To contact the reporter on this story:
To contact the editor responsible for this story:
© ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
